Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
French Innovative Leukemia Organisation
ClinicalTrials.gov Identifier:
NCT00564512
First received: November 27, 2007
Last updated: July 24, 2013
Last verified: April 2009